The third annual Biomedical HIV Prevention Summit will be held December 2-4, 2018 in Los Angeles, California. NMAC believes we must highlight the role that biomedical prevention tools such as PrEP, PEP, Treatment as Prevention (TasP), and U=U have in ending the epidemic.
The conference’s logo represents a collaboration between community-based organizations (CBOs), health departments (HDs), and national organizations. Low uptake of PrEP among MSM of color presents us with serious challenges regarding the populations that will not have the advantage of the protection offered by PrEP. This meeting brings together HIV leaders to discuss, learn, and share biomedical HIV prevention interventions.
NMAC thanks Gilead for recommitting their support of this meeting. The conversations held at the Summit will focus on the effective implementation and important infrastructure needed to turn the promise of the science into an effective community-level HIV prevention option for communities most in need.
Exhibitors at the Summit have prime opportunities to engage in person-to-person access to attendees. Purchasing a booth is also a great way for your or your organization to show your dedication to ending the epidemic.
Sponsors of the Summit gain increased brand visibility, access to a diverse group of decision makers, and a platform to ensure that your organization’s message and expertise is communicated to all Summit attendees.